Dear Friends , we really miss septa sir . sir will return after a long break after completing his assignments . So till then I will keep posting the intrinsic value of the IPO as per DCF model for 6 months till the time sir returns back .
Initial Cash Flow : 240,000,000
N = No. of shares :31,250,000
CAGR : 28 %
''''g'''' Growth Rate :
Years 1-5 : 15 %
Years 6-10 : 10 %
Terminal growth rate : 5 %
Discount Rate : 10 %
.
Year ....Cash ....Growth .........Present
No . .....Flow.........Rate.............Value
.
1 . 276,000,000 .... 15 % .... 250,909,091
2 . 314,640,000 .... 14 % .... 260,033,058
3 . 355,543,200 .... 13 % .... 267,124,869
4 . 398,208,384 .... 12 % .... 271,981,684
5 . 442,011,306 .... 11 % .... 274,454,245
6 . 486,212,437 .... 10 % .... 274,454,245
7 . 529,971,556 .... 9 % .... 271,959,206
8 . 572,369,281 .... 8 % .... 267,014,494
9 . 612,435,130 .... 7 % .... 259,732,280
10.649,181,238 .... 6 % .... 250,287,470
11.681,640,300 .... 5 % ....
PV of future cash flows
1-10 years : 264,79,50,642
Terminal Value : 525,60,36,869
Total PV of FCF : 790,39,87,511
> Intrinsic Value : 253*
At 30 % Safety Margin : 177
> Issue Price : 175*
Percentage difference between TV & IV : 66 %
> Recommendation : Apply
* The Companyโs quality control lab strictly adheres to the guidelines, protocols of the US FDA ( Page # 130 ).
* Company''''s revenue generated from USA is more than 60 % , so in future US FDA can be headache like pharma companies if quality control is not as per guideline.
* Apex stands much better than its peers Waterbase and Zeal Aqua but Avanti Feed outperform all the stocks . Recently a week before it posted robust result of June Quarter . Standalone Profit increased from 47 cr. to 142 cr. and consolidated profit increased from 49 cr. to 149 cr. Stock touched 52 week high giving return of more than 4x in a year ...!!!!
Thank You & All the Best...
๐๐